DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kerr RS. et al.
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.
Lancet Oncol 2016;
17: 1543-1557
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.